http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080055914-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2006-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d384ef64f310cdc5554cbf321e81214c |
| publicationDate | 2008-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20080055914-A |
| titleOfInvention | Administration regimen of 5- (2-chlorophenyl) -1,2-dihydro-7-fluoro-8-methoxy-3-methyl-pyrazolo [3,4-k] [1,4] benzodiazepine |
| abstract | The present invention is the use of a compound of formula (I) for the preparation of a medicament for the treatment of cancer; As well as methods of treating cancer by administering the above agents:n n n [Formula I]n n n n n n n n The medicament can be delivered in an amount of about 1.5 mg / m 2 / day to about 30 mg / m 2 / day. |
| priorityDate | 2005-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424726326 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398512 |
Total number of triples: 16.